Previous 10 | Next 10 |
Early preclinical data suggests VDM-001 may prevent overdose from fentanyl Anaheim, CA - ( NewMediaWire ) - December 03, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and relat...
ANAHEIM, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announces its medically-assisted weight loss prog...
Phoenix, Arizona--(Newsfile Corp. - October 22, 2019) - The Stock Day Podcast welcomed BioCorRX (OTCQB: BICX) ("the Company"), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. CFO and COO of the Company, Lourdes ...
Anaheim, CA - ( NewMediaWire ) - October 08, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that it has launched its UnCraveRx™, a medical...
Anaheim, CA - ( NewMediaWire ) - October 07, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update and reported progress on the development of BICX102, t...
PHOENIX, AZ / ACCESSWIRE / July 30, 2019 / The Stock Day Podcast welcomed BioCorRx (OTCQB:BICX) (“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. COO and CFO, Lourdes Felix, ...
AUSTIN, Texas, July 29, 2019 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC QB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that Lourdes Felix, CFO, COO and Director of BioCorRx Inc....
ANAHEIM, CA, July 22, 2019 ( NewMediaWire ) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that the Company’s Director Louis Lucido appeared a...
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that the Company’s Director Loui...
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that it has launched the UnCraveRx!...
News, Short Squeeze, Breakout and More Instantly...
ANAHEIM, CA - ( NewMediaWire ) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March 31, 2024, and...
ANAHEIM, CA - ( NewMediaWire ) - April 03, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmace...
ANAHEIM, CA - ( NewMediaWire ) - April 02, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on...